Advertisements

Losartan potassium

Quick links to important sections

Losartan potassium

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Losartan potassium

What is Losartan potassium?

Property Description
Active ingredient Losartan (as Losartan potassium)
Form Oral Tablets
Pharmacological class Angiotensin II Receptor Blocker (ARB)
General purpose To lower and control blood pressure
Origin Synthetic

What is Losartan Potassium and What Class Does It Belong To?

Losartan potassium is a synthetic, prescription-only medicine with the active ingredient Losartan, used primarily to manage high blood pressure. It belongs to a major class of cardiovascular drugs known as Angiotensin II Receptor Blockers (ARBs), which act systemically throughout the body. This compound is categorized as an antihypertensive agent. The addition of potassium to the Losartan molecule creates the stable Losartan potassium salt, making the active compound suitable for delivery in its common form as an oral tablet. This classification is central to how the medication functions within the body's blood pressure regulation system.


How Does Losartan Potassium Help to Lower Blood Pressure?

The primary purpose of Losartan potassium is to promote the relaxation of blood vessels, which reduces resistance and helps lower blood pressure. The drug works by blocking the action of a naturally occurring hormone called Angiotensin II. This hormone normally instructs blood vessels to contract and narrow; by preventing this signal from reaching its receptors, Losartan allows the vessels to relax and widen, a process known as vasodilation. This specific action is why the drug is categorized as an antihypertensive agent, intended for the steady control of elevated pressure. Medications in the ARB class are established options for managing these cardiovascular conditions.


What is Losartan Potassium's Origin and Form?

Losartan potassium is a chemically synthesized, single-ingredient medication, typically manufactured as an oral tablet for daily administration. As a synthetic compound, its formulation is consistent and precise. Losartan is recognized globally as an essential medicine, highlighting its role in standard healthcare. Its positioning within the ARB class offers an alternative for patients who may not tolerate the side effects sometimes associated with other classes of blood pressure medication. The standard route of administration is oral, providing a consistent method for incorporating this treatment into a daily health routine.

Advertisements

What side effects are possible with Losartan potassium?

Possible Side Effects and Safety Information: Losartan Potassium

The safety profile of Losartan potassium, documented in official regulatory sources, outlines adverse reactions categorized by frequency and the body system affected.

Frequency-Classified Adverse Reactions

Adverse events are formally classified based on incidence rates observed in clinical trials, according to governmental standards.

Classification Examples of Officially Documented Effects
Common (up to 1 in 10) Dizziness, upper respiratory infection, nasal congestion, back pain, diarrhea, fatigue
Uncommon (up to 1 in 100) Headache, somnolence, vertigo, palpitations, nausea, vomiting, rash, myalgia, edema

These effects are grouped into System-Organ Classes (SOCs), including Nervous System Disorders, Gastrointestinal Disorders, Cardiac and Vascular Disorders, and Musculoskeletal Disorders.


Serious Adverse Reactions and Safety Constraints

The official labeling documents rare but clinically significant adverse reactions and defines safety limitations for use. Serious reactions include Angioedema (swelling of the face, lips, pharynx, and tongue), Symptomatic Hypotension (severe low blood pressure), and Hyperkalemia (high blood potassium levels).

Losartan is formally contraindicated during the second and third trimesters of pregnancy due to the documented risk of Fetal Toxicity. Caution is specifically advised for patients with existing hepatic impairment (liver problems) and renal impairment (kidney problems). Symptomatic hypotension is documented as being more likely to occur after the initial administration of the drug, particularly in volume-depleted patients. These regulatory statements collectively establish the boundaries and risk profile for Losartan potassium.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes the overdose profile of Losartan potassium as primarily involving an exaggeration of its blood pressure-lowering effect. Suspected overdose requires immediate medical attention and is managed through supportive measures.

Documented Overdose Manifestations

Domain Official Regulatory Statements
Documented Overdose Presentations The most likely manifestations are hypotension (abnormally low blood pressure) and tachycardia (rapid heart rate). Bradycardia (slow heart rate) may also occur from parasympathetic stimulation.
Physiological Systems Affected Primarily the Cardiovascular System. The Renal System is also a focus in specific population contexts.
Emergency Management Management is symptomatic and supportive. Supportive treatment may include volume expansion (e.g., intravenous fluids) to address severe hypotension.
Procedural Limitations Hemodialysis is not effective for removing Losartan or its active metabolite from the systemic circulation.
Population-Specific Note For neonates with in utero exposure, if oliguria or hypotension occurs, attention must be directed toward support of blood pressure and renal perfusion.

Required Emergency Action

Any suspected overdose, due to the potential for severe hypotension and the need for professional monitoring, mandates seeking immediate medical assistance. The regulatory profile notes that no specific antidote is known, making observation and supportive care the essential response to manage the effects on the cardiovascular system.

Advertisements

Therapeutic Uses of Losartan potassium

What Losartan Potassium Treats: Main Uses and Benefits

Losartan potassium is commonly used in managing chronic cardiovascular conditions, primarily providing support and stability when symptoms are more noticeable. The core therapeutic uses are recognized for the management of high blood pressure and the protection of organs vulnerable to its effects.

Management of Cardiovascular and Renal Stress

the medication is commonly used to help with chronically elevated blood pressure (hypertension), managing the risks associated with serious cardiovascular and cerebrovascular events, and providing support for kidney function in Type 2 Diabetes patients who also have hypertension. It is applied in conditions marked by increased physiological stress. By controlling pressure, Losartan may assist with easing the physical strain on blood vessels and the heart.

Supportive Benefits for Symptom Management

Losartan is considered relevant in clinical settings marked by heightened physiological stress. This action may assist with managing symptoms linked to organ-specific functional stress, which contributes to easing the overall symptomatic burden associated with chronic high blood pressure. This use helps maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Management of Systemic Functional Stress Losartan may assist with managing symptoms linked to organ-specific functional stress, which is a condition involving fluctuating manifestations and systemic imbalance.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Losartan potassium eligibility is strictly defined by regulatory authorities based on age, physiological status, and concurrent conditions.

Contraindicated Populations

Losartan use is strictly contraindicated for pregnant women, particularly during the second and third trimesters, due to the documented risk of fetal injury and death (fetal toxicity). It is also prohibited in patients with known hypersensitivity to Losartan or any component of the medicine. Furthermore, patients diagnosed with diabetes mellitus must not use Losartan if they are concurrently taking any medication containing aliskiren. Severe hepatic impairment is also often listed as a regulatory contraindication.

Age and Condition Restrictions

Losartan is approved for adults and for children and adolescents aged 6 to 18 years solely for the treatment of hypertension. Use is not recommended for children younger than six years old, as safety and efficacy have not been established. Use is also not recommended for patients with primary hyperaldosteronism or for those who are breastfeeding. Patients with existing hepatic impairment (not severe) or volume depletion may be eligible, but their use is conditional and requires careful consideration.

Advertisements

What should I know about interactions with other medicines?

Losartan may interact with certain other medicines, supplements, or agents, which can affect its action or increase the risk of specific side effects.

Interacting Agents and Classes:

  • Agents that Increase Potassium: Concomitant use with potassium-sparing diuretics (e.g., amiloride, spironolactone), potassium supplements, or salt substitutes containing potassium may lead to dangerously high potassium levels (hyperkalemia). This combination is generally not recommended.
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): NSAIDs, including selective COX-2 inhibitors, may reduce Losartan's blood pressure-lowering effect and increase the risk of kidney function deterioration, particularly in the elderly or those who are volume-depleted.
  • Lithium: Losartan can decrease the body’s clearance of Lithium, potentially causing increased lithium levels and toxicity. Close monitoring of serum lithium levels is necessary if used together.
  • Other Renin-Angiotensin System (RAS) Inhibitors: The combined use of Losartan with other agents that block the RAS, such as ACE inhibitors or aliskiren, is defined as 'dual blockade.' This is associated with increased risks of severe hypotension, hyperkalemia, and impaired kidney function. Coadministration with aliskiren is contraindicated in patients with diabetes.
Advertisements

Mechanism of Action

Blocking the Angiotensin II Type 1 ( AT1) Receptor

Losartan potassium is a pharmacologic agent that acts as a competitive antagonist at the Angiotensin II Type 1 ( AT1) receptor. This receptor is the primary biological target responsible for mediating the effects of the hormone Angiotensin II. By binding selectively to the AT1 receptor, Losartan prevents Angiotensin II from accessing and activating it. This interaction occurs prominently on vascular smooth muscle cells and within other tissues that regulate cardiovascular function.


Modulating the Renin-Angiotensin System (RAS) Cascade

Prevention of AT1 receptor activation interrupts the downstream signaling cascade of the Renin-Angiotensin System. This modulation restricts the typical G-protein coupled receptor-mediated cellular responses that would otherwise be triggered by Angiotensin II binding. The physiological consequence of this blockade is the suppression of Angiotensin II-mediated effects, notably vasoconstriction and the stimulation of aldosterone release. This mechanistic action results in the modulation of vascular tone and peripheral resistance within the targeted cardiovascular pathways.

Advertisements

Dosage and Administration Information

Losartan potassium is administered exclusively via the oral route. It is formulated as oral tablets in 25 mg, 50 mg, and 100 mg strengths, and a 10 mg/mL oral suspension can be prepared from the tablets for specific use cases. The standard regimen requires the medicine to be taken once daily, a frequency pattern established for long-term management.

Dosage Regimens and Administration Conditions

Use Scenario Dosage Instruction
Usual Adult Starting Dose 50 mg once daily.
Reduced Initial Dose 25 mg once daily, recommended for patients with hepatic impairment or those who are volume-depleted.
Dose Titration The amount may be adjusted after 3 to 6 weeks of therapy, based on the response, up to a maximum of 100 mg once daily.
Pediatric Dosing (6–16/18 yrs) Starting dose is 0.7 mg/kg once daily (maximum 50 mg).

The medication can be taken with or without food at the patient's convenience. For procedural consistency, taking the dose at approximately the same time daily is observed. If a daily dose is missed, it is generally indicated that the patient should not take a double dose to compensate; the normal scheduled intake should simply be resumed. The overall usage protocol defines a standardized, once-daily pattern that structures the long-term administration of Losartan potassium.

Advertisements

Recent Clinical Evidence

Losartan potassium: Recent Clinical Evidence


Evidence for Use in Managing Chronic High Blood Pressure

Losartan potassium has been studied for its role in managing chronic high blood pressure in numerous clinical trials, including large Randomized Controlled Trials (RCTs). These studies were studied for their ability to track changes in a patient's systolic and diastolic blood pressure (BP) measurements over defined time intervals. Long-term research was studied for the frequency of major events observed, such as nonfatal myocardial infarction or stroke. Research includes studies focused on adults and certain pediatric patients who are 6 years of age and older. While findings describe group patterns, they do not determine whether an individual will respond similarly.


Evidence for Use in Cardiovascular Risk Reduction

Losartan potassium was evaluated in specific large-scale, long-term studies tracking major cardiovascular events—such as stroke and myocardial infarction—specifically in patients with high blood pressure and an enlarged heart (Left Ventricular Hypertrophy or LVH). These trials were designed to monitor a composite endpoint of severe events: cardiovascular death, non-fatal myocardial infarction, and stroke. A key limitation is that the data show patterns related to event tracking that were not demonstrated to apply to the Black patient subgroup studied in the key clinical trial, indicating that the evidence for tracking cardiovascular events remains limited for this population.


Evidence for Kidney Protection in Type 2 Diabetes

Research for Losartan potassium was studied for its role in patients with Type 2 Diabetes and established diabetic kidney disease (nephropathy), particularly those who also have hypertension. This research involves dedicated, large-scale, placebo-controlled RCTs designed to monitor outcomes reflecting physiological strain or stress on the kidneys. These long-term studies examined a composite renal endpoint, which tracked the time taken to reach events such as the doubling of serum creatinine, progression to end-stage renal disease (ESRD), or death. However, the evidence is mixed or certainty remains low when considering Losartan's use in patients with early diabetic kidney disease (microalbuminuria) compared to those with established nephropathy.

Key Studies & References

  1. NIH: Losartan Study Overview (Review of ARB efficacy and use)
  2. MedlinePlus Drug Information: Losartan
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Losartan potassium (FAQ)

Q: How long after starting Losartan potassium should a patient expect to see a change in blood pressure?

According to regulatory documents, the initial blood pressure-lowering effect is described as often being substantially present within one week. However, the maximal effect may take three to six weeks of consistent use to be reached.


Q: Does Losartan potassium work immediately, or does it take time to build up in the system?

The active ingredient reaches its peak concentration in the bloodstream about one hour after the dose is taken. However, the maximal effect on blood pressure control is noted to develop gradually, often taking a few weeks to be reached.


Q: Is it common to feel tired or dizzy when first starting Losartan potassium?

Official information lists both dizziness and fatigue as common side effects. The risk of symptomatic low blood pressure (hypotension) is also noted to be highest following the initial use of the medicine.


Q: Can Losartan potassium cause a cough, and if so, how is it different from the cough caused by ACE inhibitors?

Cough is listed as a common side effect in the official product documents for Losartan potassium.


Q: Are there any specific laboratory tests that need to be monitored while taking Losartan potassium?

Monitoring of certain markers is typically performed during therapy. This often includes checking blood potassium levels and markers of kidney function, such as creatinine.


Q: Is Losartan potassium more effective for certain ethnic groups, based on research?

Official research evidence states that the benefit for reducing the risk of stroke and cardiovascular events in patients with an enlarged heart was not demonstrated in the Black patient subgroup studied in the key clinical trial.


Q: What is the 'black box warning' associated with Losartan potassium?

The medicine carries a Boxed Warning regarding Fetal Toxicity. This is a serious warning that Losartan potassium can cause injury and death to a developing fetus, and it should be discontinued as soon as possible if pregnancy is confirmed.


Q: Are older adults typically prescribed a lower dose of Losartan potassium?

Dosage adjustment is not usually necessary for the general elderly population. However, a lower starting dose may be considered for patients who are volume-depleted or have existing liver impairment.


Q: Is Losartan potassium considered a 'water pill' or diuretic?

No, Losartan potassium is not a diuretic (or 'water pill'). it belongs to a class of medicines called Angiotensin II Receptor Blockers (ARBs).


Q: How is Losartan potassium different from other blood pressure medications like Lisinopril?

Losartan potassium is an Angiotensin II Receptor Blocker (ARB) that works by preventing Angiotensin II from binding to its receptor. Lisinopril, by contrast, belongs to the ACE inhibitor class, which works by blocking the enzyme that creates Angiotensin II in the first place.


Q: Does Losartan potassium have a generic name?

Yes, the generic drug name is Losartan potassium. The most common brand name for this medicine is Cozaar.


Q: Can Losartan potassium be split or crushed?

Official regulatory information specifies that the tablet is intended to be swallowed whole with fluid.


Q: Is hair loss listed as a potential side effect of Losartan potassium?

Yes, official documents list alopecia (hair loss) as an uncommon side effect of the medicine.


Q: Is Losartan potassium associated with swelling in the face or throat?

Official documents list oedema (swelling) as an uncommon side effect. It is important to know that Angioedema, which is severe swelling of the face, lips, or tongue, is listed separately as a serious, rare adverse reaction.


Q: Is it necessary to avoid grapefruit juice while taking Losartan potassium?

An interaction with grapefruit juice is documented in the labeling. Regulatory guidance recommends avoiding grapefruit products due to the potential for reduced effectiveness of the medicine.


Q: Can vitamins and supplements interfere with the effectiveness of Losartan potassium?

There is a specific, documented risk of high potassium levels (hyperkalemia) when Losartan potassium is used with over-the-counter potassium supplements or salt substitutes that contain potassium.


Q: Does Losartan potassium interact with diabetes medications?

Losartan potassium is strictly contraindicated (prohibited) for use by patients who have diabetes mellitus and are also taking any medication containing aliskiren.


Q: Is there a risk of Losartan potassium interacting with alcohol?

Official documents note that the concentration of Losartan and its active metabolite in the blood can be higher in patients with alcohol-induced liver impairment.


Q: Can Losartan potassium be used in children? (Reason for age cutoff)

The medicine is indicated for use in children aged 6 to 18 years for the management of high blood pressure. Use is not recommended for children younger than six years old because the safety and effectiveness have not been established in that population.


Q: Is Losartan potassium a treatment option for patients who have had a heart attack?

The medicine is officially indicated for conditions that reduce the risk of major cardiovascular events, including nonfatal myocardial infarction (heart attack), in certain high-risk patients with high blood pressure.


Q: Is Losartan potassium an addictive medicine?

No, Losartan potassium is not listed as a controlled substance and is not considered an addictive medicine.


Q: Can Losartan potassium affect sexual function?

Decreased libido and erectile dysfunction/impotence are listed as uncommon side effects in official documents.


Q: Does Losartan potassium cause weight gain or weight loss?

The official side effect profile does not commonly list weight gain or weight loss. However, oedema (swelling or fluid retention) is listed as an uncommon adverse reaction.


Q: Is it common for people to take Losartan potassium with hydrochlorothiazide (HCTZ)?

Yes, a fixed-dose combination product containing Losartan potassium and the diuretic hydrochlorothiazide is approved and widely available.


Q: Is Losartan potassium known to cause joint or muscle pain?

Myalgia (muscle pain) is listed as a common side effect in official documents. Arthralgia (joint pain) and arthritis are also listed as uncommon side effects.


Q: What are the official recommendations regarding driving or operating machinery while taking Losartan potassium?

Official instructions advise caution regarding the ability to drive or operate machinery due to the potential for dizziness and drowsiness, particularly after initial use.


Q: What are the common clinical trial themes discussed in research evidence for Losartan potassium?

The primary themes of clinical trials involve tracking changes in blood pressure measurements, the frequency of major cardiovascular events (like stroke and heart attack), and outcomes related to kidney function in patients with Type 2 diabetes.


Q: What is the difference between AT1 receptor and AT2 receptor?

Losartan potassium is described as a competitive antagonist that acts selectively on the Angiotensin II Type 1 ( AT1) receptor. This is the primary site involved in the blood pressure regulation targeted by the medicine.


Q: Is there any research on Losartan potassium's potential for treating conditions other than high blood pressure and diabetic kidney disease?

Official research evidence is documented for its use in managing high blood pressure, reducing cardiovascular events in high-risk patients with Left Ventricular Hypertrophy (LVH), and treating diabetic kidney disease in patients with Type 2 diabetes.

Advertisements

How should Losartan potassium be stored and disposed of?

Losartan potassium tablets require specific storage conditions defined by regulatory documents to maintain stability.

Storage Domain Official Regulatory Requirement
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F). Brief excursions are permitted between 15 C and 30 C.
Protection Store away from excess heat, light, and moisture.
Container Keep in the original container and ensure it is kept tightly closed. Do not use the product after the expiry date.
Safety The medicine must be kept out of the sight and reach of children.

For disposal, unused or expired Losartan potassium must not be discarded via wastewater or household waste. Patients should consult a pharmacist to determine the proper method for environmentally responsible disposal of the product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Losartan potassium found in:

A-Z Index: